Robert Holmlin

Robert Holmlin

Director/Miembro de la Junta en
Xagenic, Inc.
.

Fortuna: 1 208 $ al 31/08/2026

58 años
Health Technology
Consumer Services
Finance

Perfil

Robert Erik Holmlin was the founder of GeneOhm Sciences, Inc., founded in 2001, where the title held was Vice President-Business Development from 2001 to 2012.
Current jobs include Director at Xagenic, Inc. since 2012 and Director at Innovatus Life Sciences Acquisition Corp.
since 2021.
Former jobs include President, CEO, CFO & Director at Bionano Genomics, Inc. from 2024 to 2026; President & Chief Executive Officer at GenVault Corp.
from 2010 to 2011; Independent Director at Nanosphere, Inc.; Director at Applied Proteomics, Inc.; Entrepreneur-in-Residence at Domain Associates LLC; Vice President-Marketing & Development at Becton, Dickinson & Co. from 2006 to 2008; and Chief Commercial Officer at Exiqon A from 2008 to 2009.
Education includes an MBA from The Trustees of Columbia University in The City of New York, a doctorate from California Institute of Technology, an undergraduate degree from Occidental College, and an MBA from the University of California, Berkeley.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
19/03/2026 990 ( 0,01 % ) 1 208 $ 31/08/2026

Cargos activos de Robert Holmlin

EmpresasCargoInicio
Director/Miembro de la Junta 11/09/2012
Director/Miembro de la Junta 01/03/2021

Antiguos cargos conocidos de Robert Holmlin.

EmpresasCargoFin
BIONANO GENOMICS, INC. Director Ejecutivo 05/05/2026
Director Ejecutivo 01/02/2011
EXIQON A/S Corporate Officer/Principal 01/11/2009
BECTON, DICKINSON AND COMPANY Ventas & Marketing 01/07/2008
Corporate Officer/Principal -
Ver el detalle de la experiencia de Robert Holmlin.

Formación de Robert Holmlin.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

69

Relaciones de 1er grado

14

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas14

Health Technology

Health Technology

Health Technology

Technology Services

Finance

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Finance

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN